BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 18494131)

  • 21. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.
    Fleischer DE; Overholt BF; Sharma VK; Reymunde A; Kimmey MB; Chuttani R; Chang KJ; Lightdale CJ; Santiago N; Pleskow DK; Dean PJ; Wang KK
    Gastrointest Endosc; 2008 Nov; 68(5):867-76. PubMed ID: 18561930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned.
    Velanovich V
    Surg Endosc; 2009 Oct; 23(10):2175-80. PubMed ID: 19263139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
    Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
    Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
    Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
    Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Weusten BLAM; Bisschops R; Dinis-Ribeiro M; di Pietro M; Pech O; Spaander MCW; Baldaque-Silva F; Barret M; Coron E; Fernández-Esparrach G; Fitzgerald RC; Jansen M; Jovani M; Marques-de-Sa I; Rattan A; Tan WK; Verheij EPD; Zellenrath PA; Triantafyllou K; Pouw RE
    Endoscopy; 2023 Dec; 55(12):1124-1146. PubMed ID: 37813356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial.
    Pouw RE; Künzli HT; Bisschops R; Sondermeijer CM; Koch AD; Didden P; Gotink AW; Schoon EJ; Curvers WL; Bergman JJGHM; Weusten BLAM
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):566-574. PubMed ID: 29934224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry.
    Ghorbani S; Tsai FC; Greenwald BD; Jang S; Dumot JA; McKinley MJ; Shaheen NJ; Habr F; Coyle WJ
    Dis Esophagus; 2016 Apr; 29(3):241-7. PubMed ID: 25708903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.
    dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
    Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
    Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
    Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
    Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent disease following endoscopic ablation of Barrett's high-grade dysplasia with spray cryotherapy.
    Halsey KD; Chang JW; Waldt A; Greenwald BD
    Endoscopy; 2011 Oct; 43(10):844-8. PubMed ID: 21826629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
    van Vilsteren FG; Bergman JJ
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):55-74, vi. PubMed ID: 19951794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma.
    Lopes CV; Hela M; Pesenti C; Bories E; Caillol F; Monges G; Giovannini M
    Surg Endosc; 2007 May; 21(5):820-4. PubMed ID: 17294308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.
    Orman ES; Li N; Shaheen NJ
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1245-55. PubMed ID: 23644385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period.
    van Munster S; Nieuwenhuis E; Weusten BLAM; Alvarez Herrero L; Bogte A; Alkhalaf A; Schenk BE; Schoon EJ; Curvers W; Koch AD; van de Ven SEM; de Jonge PJF; Tang TJ; Nagengast WB; Peters FTM; Westerhof J; Houben MHMG; Bergman JJ; Pouw RE;
    Gut; 2022 Feb; 71(2):265-276. PubMed ID: 33753417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.